Pulse Biosciences (PLSE) Current Leases (2019 - 2025)

Pulse Biosciences' Current Leases history runs 7 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• In Q4 2025, Current Leases rose 15.87% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 15.87% YoY), while the FY2025 annual figure was $1.6 million, up 15.87% from the prior year.
• Current Leases was $1.6 million for Q4 2025 at Pulse Biosciences, up from $1.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.6 million in Q4 2025 to a low of $629000.0 in Q1 2021.
• Historically, Current Leases has averaged $1.1 million across 5 years, with a median of $1.0 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Current Leases jumped 541.84% in 2021, then slipped 15.31% in 2022.
• A 5-year view of Current Leases shows it stood at $1.1 million in 2021, then retreated by 15.31% to $896000.0 in 2022, then advanced by 18.08% to $1.1 million in 2023, then grew by 28.07% to $1.4 million in 2024, then rose by 15.87% to $1.6 million in 2025.
• The last three Current Leases figures came in at $1.6 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.